Search

Author/Creator Leis, Jose F.

1. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. Issue 5 (22nd March 2017)

Authors:
Rosenthal, Allison; Dueck, Amylou C.; Ansell, Stephen; Gano, Katherine; Conley, Christopher; Nowakowski, Grzegorz S.; Camoriano, John; Leis, Jose F.; Mikhael, Joseph R.; Keith Stewart, A.; Inwards, David; Dingli, David; Kumar, Shaji; Noel, Pierre; Gertz, Morie; Porrata, Luis; Russell, Stephen; Co...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 5(2017:May)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. Issue 9 (2nd September 2018)

Authors:
Sonbol, Mohamad Bassam; Hilal, Talal; Dueck, Amylou C.; Rosenthal, Allison C.; Conley, Christopher R.; Kosiorek, Heidi E.; Ginos, Brenda F.; Gano, Katherine M.; Nichols, Craig S.; Leis, Jose F.; Johnston, Patrick B.; Habermann, Thomas M.; Northfelt, Donald W.; Bergsagel, Peter Leif; Inwards, Davi...
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 9(2018)
Page Start:
2128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Issue 3 (13th December 2019)

Authors:
Hampel, Paul J.; Call, Timothy G.; Ding, Wei; Muchtar, Eli; Kenderian, Saad S.; Wang, Yucai; Leis, Jose F.; Witzig, Thomas E.; Koehler, Amber B.; Fonder, Amie L.; Schwager, Susan M.; Rabe, Kari G.; Van Dyke, Daniel L.; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
American journal of hematology
Issue:
Volume 95:Issue 3(2020:Mar.)
Page Start:
E57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. (20th September 2013)

Authors:
Ding, Wei; Shanafelt, Tait D.; Lesnick, Connie E.; Erlichman, Charles; Leis, Jose F.; Secreto, Charla; Sassoon, Traci R.; Call, Timothy G.; Bowen, Deborah A.; Conte, Michael; Kumar, Shaji; Kay, Neil E.
Journal:
British journal of haematology
Issue:
Volume 164:Number 1(2014:Jan.)
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Issue 8 (1st June 2017)

Authors:
Larsen, Jeremy T.; Shanafelt, Tait D.; Leis, Jose F.; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Je...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 8(2017:Aug.)
Page Start:
759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Issue 7 (3rd July 2017)

Authors:
Shanafelt, Tait D.; Parikh, Sameer A.; Noseworthy, Peter A.; Goede, Valentin; Chaffee, Kari G.; Bahlo, Jasmin; Call, Timothy G.; Schwager, Susan M.; Ding, Wei; Eichhorst, Barbara; Fischer, Kirsten; Leis, Jose F.; Chanan-Khan, Asher Alban; Hallek, Michael; Slager, Susan L.; Kay, Neil E.
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 7(2017)
Page Start:
1630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. (16th August 2018)

Authors:
Hampel, Paul J.; Larson, Melissa C.; Kabat, Brian; Call, Timothy G.; Ding, Wei; Kenderian, Saad S.; Bowen, Deborah; Boysen, Justin; Schwager, Susan M.; Leis, Jose F.; Chanan‐Khan, Asher A.; Muchtar, Eli; Hanson, Curtis A.; Slager, Susan L.; Kay, Neil E.; Chaffee, Kari G.; Shanafelt, Tait D.; Pari...
Journal:
British journal of haematology
Issue:
Volume 183:Number 3(2018)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation. Issue 8 (2nd July 2020)

Authors:
Mountjoy, Luke; Jain, Tania; Kunze, Katie L.; Khera, Nandita; Sproat, Lisa Z.; Jennifer, Woodburn; McCallen, Margaret; Leis, Jose F.; Noel, Pierre; Slack, James L.; Palmer, Jeanne
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 8(2020)
Page Start:
1996
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia. (16th July 2022)

Authors:
Hampel, Paul J.; Rabe, Kari G.; Call, Timothy G.; Ding, Wei; Leis, Jose F.; Kenderian, Saad S.; Muchtar, Eli; Wang, Yucai; Koehler, Amber B.; Parrondo, Ricardo; Schwager, Susan M.; Shi, Min; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
British journal of haematology
Issue:
Volume 199:Number 2(2022)
Page Start:
239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗